Nagai, Kei
Nansai, Keisuke
Funding for this research was provided by:
Japan Society for the Promotion of Science London (23K11528)
Article History
Received: 12 December 2024
Accepted: 17 February 2025
First Online: 19 March 2025
Declarations
:
: Ethics approval and informed consent: Because this study did not involve human participants or animals, ethics approval was not required.
: Not applicable.
: K. Nagai has received lecture fees from AstraZeneca K.K, Nippon Boehringer Ingelheim Co., Ltd., Mochida Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., Kissei Pharmaceutical Co., Ltd., Torii Pharmaceutical Co., Ltd., and Daiichi Sankyo Healthcare Co., Ltd.